EFRIS URA Commodity Codes

Cranial cavity, percutaneous approach

85811800 Category

Cranial cavity, percutaneous approach is an EFRIS commodity class (code 85811800) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

23 items in this category

  • 85811808Introduction of analgesics, hypnotics, sedatives into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811818Introduction of anti-inflammatory into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811805Introduction of anti-inflammatory into cranial nerves, percutaneous approach
    Exempt
  • 85811813Introduction of autologous somatic stem cells into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811806Introduction of destructive agent into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811801Introduction of destructive agent into cranial nerves, percutaneous approach
    Exempt
  • 85811816Introduction of electrolytic and water balance substance into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811815Introduction of embryonic stem cells into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811823Introduction of liquid brachytherapy radioisotope into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811814Introduction of local anesthetic into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811804Introduction of local anesthetic into cranial nerves, percutaneous approach
    Exempt
  • 85811821Introduction of monoclonal antibody into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811812Introduction of nonautologous somatic stem cells into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811817Introduction of nutritional substance into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811819Introduction of other anti-infective into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811822Introduction of other antineoplastic into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811809Introduction of other diagnostic substance into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811807Introduction of other gas into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811811Introduction of other therapeutic substance into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811802Introduction of other therapeutic substance into cranial nerves, percutaneous approach
    Exempt
  • 85811820Introduction of oxazolidinones into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811810Introduction of radioactive substance into cranial cavity and brain, percutaneous approach
    Exempt
  • 85811803Introduction of regional anesthetic into cranial nerves, percutaneous approach
    Exempt